COMPREHENSIVE ASSESSMENT OF IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA IN COMORBID COURSE WITH TYPE 2 DIABETES MELLITUS. Web sci. scholars 2026, 4 (3), 47-56.